Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | adenosine kinase | 0.4043 | 1 | 1 |
Onchocerca volvulus | 0.3583 | 0.8714 | 1 | |
Entamoeba histolytica | fructokinase, putative | 0.0461 | 0 | 0.5 |
Schistosoma mansoni | adenosine kinase | 0.4043 | 1 | 1 |
Trichomonas vaginalis | ribokinase, putative | 0.0461 | 0 | 0.5 |
Entamoeba histolytica | kinase, PfkB family | 0.0461 | 0 | 0.5 |
Giardia lamblia | Ribokinase | 0.0461 | 0 | 0.5 |
Toxoplasma gondii | kinase, pfkB family protein | 0.4043 | 1 | 1 |
Mycobacterium ulcerans | carbohydrate kinase CbhK | 0.0461 | 0 | 0.5 |
Trypanosoma cruzi | adenosine kinase, putative | 0.4043 | 1 | 1 |
Entamoeba histolytica | ribokinase, putative | 0.0461 | 0 | 0.5 |
Entamoeba histolytica | Hypothetical protein T24C12.3, putative | 0.0461 | 0 | 0.5 |
Entamoeba histolytica | tagatose-6-phosphate kinase, putative | 0.0461 | 0 | 0.5 |
Mycobacterium leprae | Probable adenosine kinase adk | 0.0461 | 0 | 0.5 |
Echinococcus multilocularis | adenosine kinase | 0.4043 | 1 | 1 |
Trichomonas vaginalis | ribokinase, putative | 0.0461 | 0 | 0.5 |
Trypanosoma brucei | adenosine kinase, putative | 0.4043 | 1 | 1 |
Mycobacterium tuberculosis | Adenosine kinase | 0.0461 | 0 | 0.5 |
Mycobacterium tuberculosis | 6-phosphofructokinase PfkB (phosphohexokinase) (phosphofructokinase) | 0.0461 | 0 | 0.5 |
Trypanosoma brucei | adenosine kinase, putative | 0.4043 | 1 | 1 |
Mycobacterium tuberculosis | Ribokinase RbsK | 0.0461 | 0 | 0.5 |
Mycobacterium ulcerans | fructokinase, PfkB | 0.0461 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0461 | 0 | 0.5 |
Trichomonas vaginalis | ribokinase, putative | 0.0461 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.4043 | 1 | 1 |
Leishmania major | adenosine kinase, putative | 0.4043 | 1 | 1 |
Schistosoma mansoni | adenosine kinase | 0.4043 | 1 | 1 |
Trypanosoma cruzi | adenosine kinase, putative | 0.4043 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 156 nM | Binding affinity against human vasopressin V1b receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors | ChEMBL. | 15084136 |
Ki (binding) | = 436 nM | Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors | ChEMBL. | 15084136 |
Ki (binding) | = 664 nM | Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors | ChEMBL. | 15084136 |
Ki (binding) | = 1090 nM | Binding affinity against human vasopressin V2 receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors | ChEMBL. | 15084136 |
SI (binding) | = 3 | Selectivity index of human V1b receptor towards V1a receptor | ChEMBL. | 15084136 |
SI (binding) | = 4 | Selectivity index of human V1b receptor towards Oxytocin receptor | ChEMBL. | 15084136 |
SI (binding) | = 7 | Selectivity index of human V1b receptor towards V2 receptor | ChEMBL. | 15084136 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.